|
1
|
Kjeldsen SE, Os I and Redon J: Treatment
of hypertension and the price to pay; adverse events and
discontinuation from randomized treatment in clinical trials. J
Hypertens. 34:1489–1491. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q and
Cheng Y: Functional polymorphism of lncRNA MALAT1 contributes to
pulmonary arterial hypertension susceptibility in Chinese people.
Clin Chem Lab Med. 55:38–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rudemiller NP and Crowley SD: Interactions
between the immune and the renin-angiotensin systems in
hypertension. Hypertension. 68:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taddei S and Bruno RM: Endothelial
dysfunction in hypertension: Achievements and open questions. J
Hypertens. 34:1492–1493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Yang Y, Yang D, Tong G, Lv S, Lin
X, Chen C and Dong W: Tetrandrine prevents monocrotaline-induced
pulmonary arterial hypertension in rats through regulation of the
protein expression of inducible nitric oxide synthase and cyclic
guanosine monophosphate-dependent protein kinase type 1. J Vasc
Surg. 64:1468–1477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao Y, Jiang Z, Zeng Z, Liu Y, Gu Y, Ji Y,
Zhao Y and Li Y: Bcl-2 silencing attenuates hypoxia-induced
apoptosis resistance in pulmonary microvascular endothelial cells.
Apoptosis. 21:69–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Santovito D and Weber C: Zooming in on
microRNAs for refining cardiovascular risk prediction in secondary
prevention. Eur Heart J. 38:524–528. 2017.PubMed/NCBI
|
|
8
|
Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN,
Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW and Huang TS:
miR-122-mediated translational repression of PEG10 and its
suppression in human hepatocellular carcinoma. J Transl Med.
14:2002016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang C, Chen X, Wang X, Ji A, Jiang L,
Sang F and Li F: miR-135a acts as a tumor suppressor in gastric
cancer in part by targeting KIFC1. Onco Targets Ther. 9:3555–3563.
2016.PubMed/NCBI
|
|
10
|
Zhang H, Cao H, Xu D and Zhu K:
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by
targeting the PTEN/AKT pathway. Onco Targets Ther. 9:3579–3588.
2016.PubMed/NCBI
|
|
11
|
Wang P, Xu J, Hou Z, Wang F, Song Y, Wang
J, Zhu H and Jin H: miRNA-34a promotes proliferation of human
pulmonary artery smooth muscle cells by targeting PDGFRA. Cell
Prolif. 49:484–493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Elia L and Condorelli G: MicroRNAs and
pulmonary hypertension: A tight link. Cardiovasc Res. 111:163–164.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo Z, Feng C, Hu P, Chen Y, He XF, Li Y
and Zhao J: Serum microRNA-199a/b-3p as a predictive biomarker for
treatment response in patients with hepatocellular carcinoma
undergoing transarterial chemoembolization. Onco Targets Ther.
9:2667–2674. 2016.PubMed/NCBI
|
|
14
|
Wang J, Sun W, Wells GA, Li Z, Li T, Wu J,
Zhang Y, Liu Y, Li L, Yu Y, et al: Differences in prevalence of
hypertension and associated risk factors in urban and rural
residents of the northeastern region of the people's republic of
china: A cross-sectional study. PLoS One. 13:e01953402018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vashukova ES, Glotov AS, Fedotov PV,
Efimova OA, Pakin VS, Mozgovaya EV, Pendina AA, Tikhonov AV,
Koltsova AS and Baranov VS: Placental microRNA expression in
pregnancies complicated by superimposed preeclampsia on chronic
hypertension. Mol Med Rep. 14:22–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Samanta S, Balasubramanian S, Rajasingh S,
Patel U, Dhanasekaran A, Dawn B and Rajasingh J: MicroRNA: A new
therapeutic strategy for cardiovascular diseases. Trends Cardiovasc
Med. 26:407–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pang Y and Thomas P: Additive effects of
low concentrations of estradiol-17β and progesterone on nitric
oxide production by human vascular endothelial cells through shared
signaling pathways. J Steroid Biochem Mol Biol. 165:258–267. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soufi-Zomorrod M, Hajifathali A, Kouhkan
F, Mehdizadeh M, Rad SM and Soleimani M: MicroRNAs modulating
angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs.
Tumour Biol. 37:9527–9534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu Z, Zhang W, Gao S, Jiang Q, Xiao Z, Ye
L and Zhang X: MiR-506 suppresses liver cancer angiogenesis through
targeting sphingosine kinase 1 (SPHK1) mRNA. Biochem Biophys Res
Commun. 468:8–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu RR, Li J, Gong JY, Kuang F, Liu JY,
Zhang YS, Ma QL, Song CJ, Truax AD, Gao F, et al: MicroRNA-141
regulates the expression level of ICAM-1 on endothelium to decrease
myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ
Physiol. 309:H1303–H1313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang X, Lei S, Long J, Liu X and Wu Q:
MicroRNA-199a-5p inhibits tumor proliferation in melanoma by
mediating HIF-1α. Mol Med Rep. 13:5241–5247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Li S, Zhou Q, Sun Q, Shen S, Zhou
Y, Bei Y and Li X: Qiliqiangxin attenuates phenylephrine-induced
cardiac hypertrophy through downregulation of mir-199a-5p. Cell
Physiol Biochem. 38:1743–1751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hashemi Gheinani A, Burkhard FC, Rehrauer
H, Aquino Fournier C and Monastyrskaya K: MicroRNA MiR-199a-5p
regulates smooth muscle cell proliferation and morphology by
targeting WNT2 signaling pathway. J Biol Chem. 290:7067–7086. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Liu G, Zhang H and Wang J:
MiRNA-199a-5p influences pulmonary artery hypertension via
downregulating Smad3. Biochem Biophys Res Commun. 473:859–866.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Negroni A, Colantoni E, Vitali R, Palone
F, Pierdomenico M, Costanzo M, Cesi V, Cucchiara S and Stronati L:
NOD2 induces autophagy to control AIEC bacteria infectiveness in
intestinal epithelial cells. Inflamm Res. 65:803–813. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rojo de la Vega M, Dodson M, Gross C,
Mansour HM, Lantz RC, Chapman E, Wang T, Black SM, Garcia JG and
Zhang DD: Role of Nrf2 and autophagy in acute lung injury. Curr
Pharmacol Rep. 2:91–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Song Y, Liu L, Hou N, An X, Zhan D,
Li Y, Zhou L, Li P, Yu L, et al: miR-199a impairs autophagy and
induces cardiac hypertrophy through mTOR activation. Cell Death
Differ. 24:1205–1213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu N, Zhang J, Shen C, Luo Y, Xia L, Xue F
and Xia Q: Cisplatin-induced downregulation of miR-199a-5p
increases drug resistance by activating autophagy in HCC cell.
Biochem Biophys Res Commun. 423:826–831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fan XY, Tian C, Wang H, Xu Y, Ren K, Zhang
BY, Gao C, Shi Q, Meng G, Zhang LB, et al: Activation of the
AMPK-ULK1 pathway plays an important role in autophagy during prion
infection. Sci Rep. 5:147282015. View Article : Google Scholar : PubMed/NCBI
|
